Siemens Japanese Subsidiary Launches New Immunoassy System
This article was originally published in PharmAsia News
Executive Summary
Tokyo-based Siemens Healthcare Diagnostics launched Immulite 2000 XPi immunoassay in Japan. The device is used to detect onset of diseases by identifying and analyzing certain proteins from blood samples. The device requires a very small amount of specimen and also needs less maneuvering. Priced at ¥25 million, the device is marketed by the Japanese subsidiary of Siemens medical device and diagnostics unit. (Click here for more - Japanese language)"Siemens Immunoassy System Uses Less Specimen And Easy To Operate" - Nikkei Sangyo News (1/29/2010)